When is FOMO going to hit? Amicus has seen the data and has helped DMX gain a very low bar for approval from the FDA. Amicus are obviously tight with the FDA. Now, as Nina has said, they don’t know if DMX200 has just been better than a placebo or it’s smashed it out of the park. If it’s a home run in Q3 CY 2025, good luck getting into this stock at less than a $3 handle come September.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
0.015(2.73%) |
Mkt cap ! $339.0M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 57.5¢ | 55.5¢ | $1.770M | 3.142M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 70978 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 38029 | 2 |
View Market Depth
| Last trade - 15.56pm 25/07/2025 (20 minute delay) ? |
| DXB (ASX) Chart |